Latest News

View All Recent News »

Alimera Sciences Announces Presentation Time Change At UBS Global Healthcare Conference

May 18, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced a change in the Company's presentation time at this...

Read More »

Alimera Sciences To Present At UBS Global Healthcare Conference

May 11, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that its management will present at the UBS Global...

Read More »

Alimera Sciences Reports First Quarter 2015 Financial Results

May 07, 2015 -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced financial results for the first quarter ended March 31,...

Read More »